Recall record Z-0754-2012 for Integra LifeSciences Corp. d.b.a. Integra Pain Management. View source facts, labeled dates, and the original FDA record.
Current package insert was revised to include additional warning information related to the potential hazards of an unapproved off-label use of Xylocaine.
Source facts
Action
Integra sent an Urgent: Medical Device Correction Notice letter dated December 21, 2011 to all affected customers. The letter identified the product, problem and actions to be taken. Integra is requesting that customers further distribute the communications along with the package insert to all appropriate health care practitioners at their facility. The letter instructs customers to complete and return the attached acknowledgement form by fax to 609-750-7999. For questions or concerns call 609-750-2814.
Initiated
2011-12-21
Root cause
Labeling False and Misleading
Terminated
2012-05-10
Distribution
(USA) Nationwide Distribution
Recall number
Z-0754-2012
Recall status
Terminated
CDRH record ID
106502
FDA classified
2012-01-13
Recall event number
60798
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.